1400 related articles for article (PubMed ID: 25454795)
1. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator arrests Alzheimer's disease pathogenesis.
Oh SB; Byun CJ; Yun JH; Jo DG; Carmeliet P; Koh JY; Lee JY
Neurobiol Aging; 2014 Mar; 35(3):511-9. PubMed ID: 24126163
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-beta levels are significantly reduced and spatial memory defects are rescued in a novel neuroserpin-deficient Alzheimer's disease transgenic mouse model.
Fabbro S; Schaller K; Seeds NW
J Neurochem; 2011 Sep; 118(5):928-38. PubMed ID: 21689108
[TBL] [Abstract][Full Text] [Related]
5. A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-β Load and Improves Memory in an Animal Model of Alzheimer's Disease.
Akhter H; Huang WT; van Groen T; Kuo HC; Miyata T; Liu RM
J Alzheimers Dis; 2018; 64(2):447-457. PubMed ID: 29914038
[TBL] [Abstract][Full Text] [Related]
6. Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.
Liu RM; van Groen T; Katre A; Cao D; Kadisha I; Ballinger C; Wang L; Carroll SL; Li L
Neurobiol Aging; 2011 Jun; 32(6):1079-89. PubMed ID: 19604604
[TBL] [Abstract][Full Text] [Related]
7. Ageing and amyloid-beta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms.
Cacquevel M; Launay S; Castel H; Benchenane K; Chéenne S; Buée L; Moons L; Delacourte A; Carmeliet P; Vivien D
Neurobiol Dis; 2007 Aug; 27(2):164-73. PubMed ID: 17566751
[TBL] [Abstract][Full Text] [Related]
8. tPA Deficiency Underlies Neurovascular Coupling Dysfunction by Amyloid-β.
Park L; Zhou J; Koizumi K; Wang G; Anfray A; Ahn SJ; Seo J; Zhou P; Zhao L; Paul S; Anrather J; Iadecola C
J Neurosci; 2020 Oct; 40(42):8160-8173. PubMed ID: 32928888
[TBL] [Abstract][Full Text] [Related]
9. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration.
Melchor JP; Pawlak R; Strickland S
J Neurosci; 2003 Oct; 23(26):8867-71. PubMed ID: 14523088
[TBL] [Abstract][Full Text] [Related]
10. Urokinase-Type Plasminogen Activator Protects Cerebral Cortical Neurons from Soluble Aβ-Induced Synaptic Damage.
Diaz A; Merino P; Guo JD; Yepes MA; McCann P; Katta T; Tong EM; Torre E; Rangaraju S; Yepes M
J Neurosci; 2020 May; 40(21):4251-4263. PubMed ID: 32332118
[TBL] [Abstract][Full Text] [Related]
11. beta-amyloid deposits in transgenic mice expressing human beta-amyloid precursor protein have the same characteristics as those in Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Tasaki Y; Watanabe T; Miyata K; Yamaguchi T
Neuroscience; 2001; 104(2):299-310. PubMed ID: 11377835
[TBL] [Abstract][Full Text] [Related]
12. The plasmin system is induced by and degrades amyloid-beta aggregates.
Tucker HM; Kihiko M; Caldwell JN; Wright S; Kawarabayashi T; Price D; Walker D; Scheff S; McGillis JP; Rydel RE; Estus S
J Neurosci; 2000 Jun; 20(11):3937-46. PubMed ID: 10818128
[TBL] [Abstract][Full Text] [Related]
13. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.
Kawarabayashi T; Younkin LH; Saido TC; Shoji M; Ashe KH; Younkin SG
J Neurosci; 2001 Jan; 21(2):372-81. PubMed ID: 11160418
[TBL] [Abstract][Full Text] [Related]
15. Enhanced clearance of Abeta in brain by sustaining the plasmin proteolysis cascade.
Jacobsen JS; Comery TA; Martone RL; Elokdah H; Crandall DL; Oganesian A; Aschmies S; Kirksey Y; Gonzales C; Xu J; Zhou H; Atchison K; Wagner E; Zaleska MM; Das I; Arias RL; Bard J; Riddell D; Gardell SJ; Abou-Gharbia M; Robichaud A; Magolda R; Vlasuk GP; Bjornsson T; Reinhart PH; Pangalos MN
Proc Natl Acad Sci U S A; 2008 Jun; 105(25):8754-9. PubMed ID: 18559859
[TBL] [Abstract][Full Text] [Related]
16. Cortical glucose metabolism is altered in aged transgenic Tg2576 mice that demonstrate Alzheimer plaque pathology.
Bigl M; Apelt J; Eschrich K; Schliebs R
J Neural Transm (Vienna); 2003 Jan; 110(1):77-94. PubMed ID: 12541014
[TBL] [Abstract][Full Text] [Related]
17. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
18. Beta-amyloid (Abeta) causes detachment of N1E-115 neuroblastoma cells by acting as a scaffold for cell-associated plasminogen activation.
Kranenburg O; Bouma B; Gent YY; Aarsman CJ; Kayed R; Posthuma G; Schiks B; Voest EE; Gebbink MF
Mol Cell Neurosci; 2005 Mar; 28(3):496-508. PubMed ID: 15737740
[TBL] [Abstract][Full Text] [Related]
19. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.
Liu P; Reichl JH; Rao ER; McNellis BM; Huang ES; Hemmy LS; Forster CL; Kuskowski MA; Borchelt DR; Vassar R; Ashe KH; Zahs KR
J Alzheimers Dis; 2017; 56(2):743-761. PubMed ID: 28059792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
